Flosonics Medical, a Sudbury, Ontario, Canada-based medical device company, received CAD$7.5M in Venture Debt from RBCx.
The company intends to use the funds to expand the reach of FloPatch and consolidate its position as a player in life sciences innovation.
Founded in 2015 and led by CEO Joe Eibl, Flosonics Medical is a medical device company engaged in the research and development of innovative ultrasound technology. FloPatch is a wireless, wearable Doppler ultrasound device that conducts rapid, repeatable hemodynamic assessments to understand a patient’s fluid responsiveness, allowing clinicians to deliver timely and effective interventions. By streamlining critical decisions, FloPatch helps healthcare providers optimize sepsis care, reduce fluid-related complications, and improve patient outcomes.
FinSMEs
03/03/2025